Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M.R. Ackroyd
Observed names:
M Ackroyd,
M. Ackroyd,
M. R. Ackroyd,
Mark R. Ackroyd,
Mark. R. Ackroyd
Institutions:
University of London,
Royal Veterinary College
Observed institutions:
University of London,
Royal Veterinary College,
Hammersmith Hospital,
University of Manchester,
Imperial College London
OpenAlex ID:
A5034728159
Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies
2008
·
M. R. Ackroyd
, L. Skordis
, et al.
·
Brain
·
64
PDF
Muscular dystrophies due to defective glycosylation of dystroglycan.
2007
·
F Muntoni
, M Brockington
, et al.
·
Europe PMC (PubMed Central)
·
58
The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice
2013
·
Charlotte Whitmore
, Marta Fernandez-Fuente
, et al.
·
Human Molecular Genetics
·
37
PDF
Fukutin-Related Protein Alters the Deposition of Laminin in the Eye and Brain
2011
·
Mark R. Ackroyd
, Charlotte Whitmore
, et al.
·
Journal of Neuroscience
·
28
PDF
The identification of circular extrachromosomal DNA in the nuclear genome ofTrypanosoma brucei
2003
·
N. S. Alsford
, M. Navarro
, et al.
·
Molecular Microbiology
·
21
PDF
P2.16 Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease
2011
·
C. Whitmore
, M.R. Ackroyd
, et al.
·
Neuromuscular Disorders
·
1
PDF
C.P.3.15 A new mouse model for dystroglycanopathies associated with mutations in FKRP
2007
·
M. Ackroyd
, M. Kaluarachchi
, et al.
·
Neuromuscular Disorders
·
1
G.P.6 Assessing the long term expression of LARGE as a potential therapy in a mouse model of LGMD2I
2012
·
C. Whitmore
, H. Booler
, et al.
·
Neuromuscular Disorders
PDF
P28 Assessing the therapeutic potential of LARGE in a mouse model for the limb girdle muscular dystrophies
2012
·
C. Whitmore
, H. Booler
, et al.
·
Neuromuscular Disorders
P2.15 Assessing the therapeutic potential of LARGE in a new mouse model of dystroglycanopathy
2011
·
C. Whitmore
, M.R. Ackroyd
, et al.
·
Neuromuscular Disorders
P2.12 Generation of a new mouse model for therapeutic testing in the dystroglycanopathies
2011
·
C. Whitmore
, M.R. Ackroyd
, et al.
·
Neuromuscular Disorders
O17 Novel insight in muscle and brain involvement in dystroglycanopathies
2011
·
M.R. Ackroyd
, C. Whitmore
, et al.
·
Neuromuscular Disorders
P11 A reduction in the expression of Fukutin-related protein leads to the altered deposition of multiple laminin alpha chains in a mouse model for Muscle Eye Brain disease
2011
·
M.R. Ackroyd
, C. Whitmore
, et al.
·
Neuromuscular Disorders
P12 Generation of a new mouse model for therapeutic testing in the dystroglycanopathies
2011
·
C. Whitmore
, M.R. Ackroyd
, et al.
·
Neuromuscular Disorders
P17 Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease
2011
·
C. Whitmore
, M.R. Ackroyd
, et al.
·
Neuromuscular Disorders
EM.P.2.10 Deficiency of multiple alpha dystroglycan ligand interactions underlie the phenotype of a FKRP-deficient mouse model for muscle eye brain disease
2009
·
M.R. Ackroyd
, S. Prior
, et al.
·
Neuromuscular Disorders
G.P.2.10 Characterisation of the brain and eye phenotype of a FKRP knock-down mouse model of Muscle–Eye–Brain disease
2008
·
M.R. Ackroyd
, L. Skordis
, et al.
·
Neuromuscular Disorders
Show more works
View as search
Works count:
17
Citation count:
210
H-index:
5
I10-index:
5
Year
Topic
Type
